By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sucampo Pharmaceuticals, Inc. 

4733 Bethesda Avenue
Suite 450
Bethesda  Maryland  20814  U.S.A.
Phone: 301-961-3400 Fax: 301-961-3440



Start Up

Company News
Sucampo (SCMP) Announces Webcast Of Its Presentation At Cantor Fitzgerald's Inaugural Healthcare Conference 7/1/2015 7:54:03 AM
Sucampo (SCMP) Release: China Food And Drug Administration Accepts IND For Pivotal Study Of AMITIZA (Lubiprostone) 6/16/2015 7:33:58 AM
Sucampo (SCMP) Announces Webcast Of Its Presentation At The Jefferies and Co. 2015 Healthcare Conference 5/27/2015 7:23:21 AM
Sucampo (SCMP) Announces Clinical Data On Lubiprostone To Be Presented At Digestive Disease Week 5/17/2015 4:51:21 PM
Sucampo (SCMP) Announces Webcast Of Its Presentation At The 2015 UBS Global Healthcare Conference 5/14/2015 10:30:48 AM
Sucampo (SCMP) And Harbin Gloria Pharmaceuticals (002437.SZ) Enter Into Licensing Agreement For AMITIZA (Lubiprostone) In China 5/11/2015 3:58:43 PM
FDA Grants Fast Track Designation To Sucampo (SCMP)'s Cobiprostone For Oral Mucositis 5/8/2015 7:59:08 AM
R-Tech Ueno, Sucampo (SCMP) Dissolve Unoprostone Pacts 5/7/2015 6:04:53 AM
Sucampo (SCMP) Announces First Quarter 2015 Earnings Call 4/22/2015 1:15:49 PM
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR 4/13/2015 10:46:01 AM